GoHealth 2025 Q3 Earnings Net Loss Widens 2142.9% Amid Market Challenges

GoHealth (GOCO) reported a dramatic widening of its net loss in Q3 2025, missing both revenue and earnings expectations. The company cited strategic shifts in the Medicare Advantage market, including a deliberate reduction in volume to prioritize retention and quality. Despite a $34.19 million revenue decline, management emphasized long-term value creation through cost discipline and platform efficiency.

Revenue

GoHealth’s total revenue plummeted 71.1% to $34.19 million in Q3 2025, with Total Medicare Revenue accounting for $26.90 million. This segment was driven by a robust Medicare Agency Revenue of $26.29 million, complemented by Commission Revenue of $22.17 million. Partner Marketing and Other Revenue contributed $4.12 million, while Total Other Revenue reached $7.29 million, primarily from Other Non-Agency Revenue ($6.89 million) and Other Agency Revenue ($402,000). The Medicare Non-Agency Revenue segment, at $610,000, highlighted the company’s focus on diversified income streams amid market volatility.

Earnings/Net Income

The company swung to a loss of $11.80 per share in Q3 2025, a 2134.5% negative change from a $0.58 profit in the prior-year period. Net income turned to a $313.92 million loss, a 2142.9% deterioration from $15.37 million in 2024 Q3. The EPS result reflects a dramatic shift from profit to loss, underscoring ongoing financial challenges.

Post-Earnings Price Action Review

Following the earnings release, GoHealth’s stock price plummeted 21.06% on the latest trading day, 26.20% over the past week, and 42.37% month-to-date. The steep decline mirrored broader investor concerns about the company’s financial stability and market position. Analysts noted that the stock’s performance aligned with the company’s admission of sustained losses over five years, signaling prolonged uncertainty for stakeholders.

CEO Commentary

CEO Vijay Kotte emphasized a strategic pivot toward quality over quantity, prioritizing retention, cash preservation, and efficient platform investments. He highlighted alignment with health plan priorities, including targeted growth in Special Needs Plans (SNPs), where GoHealth leverages proprietary technology and agent training. Kotte acknowledged market challenges, such as reduced commissions and suppressed consumer-preferred plans, but expressed confidence in disciplined long-term value creation.

Guidance

Management expects the Medicare Advantage market to stabilize as benefit designs and cost structures normalize, enabling revenue growth with improved margins. While no specific quantitative targets were provided, Kotte underscored retention, SNP expansion, and platform efficiency as key drivers.

Additional News

In the three weeks following the earnings report, GoHealth announced a $40 million superpriority term loan facility to bolster liquidity and strategic flexibility. The CEO reiterated a disciplined approach to market rationalization, positioning the company for industry consolidation. Separately, the company confirmed access to lender support and a refreshed board to strengthen governance. Analysts highlighted GoHealth’s leadership in SNPs, with increased options for 2026, as a differentiator in a fragmented broker landscape.

Polished Transitions and Formatting

• Enhanced flow between sections with cohesive transitions.

• All numerical data preserved and formatted consistently.

• Proper punctuation and spacing applied.

• Original bold headings retained.

• Image placeholder inserted after the Post-Earnings Price Action Review section.